Dr. Cheson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6410 Rockledge Dr
Bethesda, MD 20817Phone+1 301-571-0019Fax+1 240-482-0555
Education & Training
- Tufts University School of MedicineClass of 1971
- University of Virginia Medical CenterResidency, Internal Medicine
Certifications & Licensure
- MD State Medical License 1987 - 2026
- DC State Medical License 1994 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL) Start of enrollment: 2008 Feb 01
- Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL) Start of enrollment: 2009 Feb 01
- Ofatumumab and Bendamustine for Previously Treated Chronic Lymphocytic Leukemia (CLL) Start of enrollment: 2010 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 64 citationsImproved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Grou...David A. Rizzieri, Jeffrey L. Johnson, John C. Byrd, Gerard Lozanski, Kristie A. Blum
British Journal of Haematology. 2014-04-01 - 191 citationsRole of Functional Imaging in the Management of LymphomaBruce D. Cheson
Journal of Clinical Oncology. 2011-05-10 - 3150 citationsRecommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano ClassificationBruce D. Cheson, Richard I. Fisher, Sally F. Barrington, Franco Cavalli, Lawrence H. Schwartz
Journal of Clinical Oncology. 2014-09-20
Journal Articles
- Combinations or Sequences of Targeted Agents in CLL: Is the Whole Greater Than the Sum of Its Parts (Aristotle, 360 BC)?Bruce Cheson, MD, Blood
- CALBG 50604: Risk-Adapted Treatment of Non-Bulky Early Stage Hodgkin Lymphoma Based on Interim PETDavid J Straus, Heiko Schoder, Bruce D Cheson, John C Grecula, Lale Kostakoglu, Eric D Hsi, Leslie L Popplewell, John P Leonard, Craig H Moskowitz, Brad S Kahl, Jonath..., Blood
- Real World Outcomes and Management Strategies for Venetoclax-Treated Chronic Lymphocytic Leukemia Patients in the United StatesArun K Singavi, Andrew Zelenetz, Nicole Lamanna, Bruce D Cheson, Richard R Furman, Jakub Svoboda, Stephen J Schuster, John N Allan, Chaitra S Ujjani, Haematologica
Abstracts/Posters
- Long-Term Follow-up of Follicular Lymphoma (FL) Patients (pts) Demonstrating Undetectable Minimal Residual Disease (MRD) Using a Next-Generation Based DNA Assay: Suppo...Bruce D. Cheson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Treatment Sequences and Outcomes of Patients with CLL Treated with Venetoclax and Other Novel Agents Post Introduction of Novel TherapiesBruce D. Cheson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Toxicities and Outcomes of Acalabrutinib-Treated Patients with Chronic Lymphocytic Leukemia: A Retrospective Analysis of Real World PatientsBruce D. Cheson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Addressing Current Questions and Controversies in the Management of Lymphomas and Chronic Lymphocytic Leukemia (Part 1 of a 2-Part Series)61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Bortezomib Maintenance (BM) or Consolidation (BC) Following Aggressive Immunochemotherapy and Autologous Stem Cell Transplant (ASCT) for Untreated Mantle Cell Lymphoma...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- External Validation and Revision of Thrombosis Lymphoma /Throly/ Score2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
- 4 Oncologists on the MoveJune 8th, 2021
- Brentuximab Vedotin plus Nivolumab as Chemotherapy-Free Strategy for Hodgkin Lymphoma in Older PatientsOctober 19th, 2020
- Thanks. Feedback Improves Google AdsSeptember 17th, 2019
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: